# A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

> **NCT00001079** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 80 (—)

## Conditions studied

- HIV Infections
- HIV Wasting Syndrome

## Interventions

- **DRUG:** Testosterone enanthate
- **DRUG:** Megestrol acetate

## Key facts

- **NCT ID:** NCT00001079
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** 80 (—)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001079, "A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00001079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*